Company Analysis

Kairos Pharma, Ltd. (KAPA)

NYSE: KAPA · Pharmaceutical Preparations · Los Angeles, CA · filing with the SEC since 2023
Grade5.6
◀ Past 4.6● Present 6.0▶ Future 5.9
7 est.

Filings

104 filings since 2017 beside 21 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed May 22, 2026.

Filings a yearinsider forms included
11365325
2023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Oct 15, 2025.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Apr 28, 2025.SEC letters: 12 in the last 36 months, the newest Jan 21, 2026.A late-filing notice, Form NT 10-K, filed Mar 28, 2025.
Insider forms 21

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 8-K items 8.01, 9.01 Other event · Current report
Nov 3, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Oct 29, 2026
Oct 6, 2026 8-K items 8.01, 9.01 Other event · Current report
Sep 14, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 21, 2026 8-K items 3.03, 5.03, 7.01, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Aug 12, 2026 10-Q Quarterly report Jun 30, 2026
Jul 22, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Jul 16, 2026
Jul 15, 2026 8-K items 8.01, 9.01 Other event · Current report
Jun 30, 2026 8-K item 5.07 Shareholder vote · Current report Jun 29, 2026
Jun 4, 2026 8-K items 8.01, 9.01 Other event · Current report
May 26, 2026 DEFA14A Extra proxy material
May 22, 2026 ARS Annual report to shareholders Dec 31, 2025
May 22, 2026 DEF 14A Proxy statement
May 18, 2026 8-K items 8.01, 9.01 Other event · Current report
May 13, 2026 10-Q Quarterly report Mar 31, 2026
May 11, 2026 PRE 14A Preliminary proxy statement
Apr 1, 2026 424B3 Shelf offering
Apr 1, 2026 424B3 Shelf offering
Mar 31, 2026 10-K Annual report Dec 31, 2025
Mar 2, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report
Feb 26, 2026 8-K items 8.01, 9.01 Other event · Current report
Jan 23, 2026 EFFECT Registration effective
Jan 21, 2026 CORRESP Reply to the SEC
Jan 15, 2026 UPLOAD SEC comment letter
Jan 13, 2026 S-3 Shelf registration
Nov 14, 2025 10-Q Quarterly report Sep 30, 2025
Oct 15, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Oct 8, 2025
Oct 7, 2025 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Oct 1, 2025
Sep 18, 2025 8-K items 8.01, 9.01 Other event · Current report
Sep 11, 2025 8-K items 8.01, 9.01 Other event · Current report
Sep 3, 2025 8-K items 8.01, 9.01 Other event · Current report
Aug 19, 2025 424B3 Shelf offering
Aug 14, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 12, 2025 10-Q Quarterly report Jun 30, 2025
Jul 28, 2025 10-K/A Annual report, amended Dec 31, 2024
Jul 15, 2025 8-K items 8.01, 9.01 Other event · Current report
Jun 12, 2025 8-K items 1.01, 5.07, 9.01 Major agreement signed; Shareholder vote · Current report Jun 10, 2025
Jun 3, 2025 8-K items 8.01, 9.01 Other event · Current report
May 16, 2025 DEFR14A Revised proxy statement
May 15, 2025 SCHEDULE 13G Large holder notice
40 of 104 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton KAPA · research, not advice